Pipeline
Non-invasive, effective topical treatments addressing unmet medical and aesthetic needs

EpiPharm has discovered that the Artemisinins are effective in the
treatment of melanocytic lesions and seborrheic keratosis.

The discovery provides the company with new non-invasive, effective
therapies addressing huge unmet medical and aesthetic needs.

Intellectual property is based on therapeutic use patents lasting until
2025 /2034

Artemisinin was discovered in 1972 by Tu Youyou, a Chinese scientist
awarded 2015 with the Nobel Prize in Medicine for her discovery.
The Artemisnin derivatives are standard treatment worldwide for P.
falciparum malaria, have been used by millions of people and their
safety profile is well documented.

EpiPharm AG, Pipeline 10/2018